Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From 3M
3M’s health care company spin-off is expected to be launched in the first half of 2024 under the name Solventum.
Medtech Insight's News We're Watching highlights medtech industry news developments you may have missed over the last few weeks.
Takeda hopes for good news on fruquintinib and TAK-755, while Bristol and SpringWorks share a goal date for their breakthrough-designated cancer treatments.
Only two breakthrough-designated novel agents remain on the US FDA drugs center’s 2023 user fee calendar, while CBER stacks up on vaccines and gene therapies under both BTD and RMAT programs.
- Medical Devices
- OTC, Consumer
- Consumables, Central Supplies
Diagnostic Imaging Equipment & Supplies
- Artificial Intelligence
- Other Names / Subsidiaries
- 3M Company
- Acelity L.P. Inc.
- Crawford Healthcare Holdings Limited
- Kinetic Concepts, Inc.
- Minnesota Mining and Manufacturing
- Scott Safety
- Systagenix Wound Management, Limited
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.